PRLB Price Today: PROTO LABS, INC. Stock Price, Quote & Chart | MEXC
This article provides a detailed stock analysis for PROTO LABS, INC. (PRLB) on the NYSE, highlighting its current price of $98.26, a market capitalization of $2.35B, and a P/E ratio of 77.08. It covers the company's recent market performance, key financial data, 52-week price range, and a company overview. The article also includes instructions on how eligible investors can buy PRLB stock on the MEXC platform.
A Look at Proto Labs Inc (PRLB) After 4.1% Gain -- GF Value $46.
Proto Labs Inc (PRLB) saw a 4.1% stock gain, reaching $98.21, but GuruFocus' GF Value™ indicates it is significantly overvalued at $46.65. The company's GF Score™ is 63/100, with strong financial strength and momentum but weak valuation and growth ranks. Insider selling and mixed guru activity suggest caution for investors.
Proto Labs stock hits 52-week high at 98.51 USD By Investing.com
Proto Labs Inc (PRLB) stock has reached a new 52-week high of $98.51, reflecting a 96.58% increase over the past year and bringing its market capitalization to $2.35 billion. Despite this impressive rally, InvestingPro analysis indicates the stock may be overvalued relative to its Fair Value. The company recently reported strong Q2 results, exceeding Wall Street expectations with record revenue and improved earnings per share, leading to an upgrade in its stock rating to Buy by Needham.
Proto Labs, Inc. (PRLB) Stock Price, News, Quote & History
This article provides a comprehensive overview of Proto Labs, Inc. (PRLB) stock, including its current price, historical performance, and key financial metrics. It details the company's operations as a digital manufacturer of custom parts, offering services like molding, CNC machining, and 3D printing. The report also includes analyst insights, earnings trends, and valuation measures for potential investors.
Industrial stock winners: Vicor, Bloom Energy lead September’s top ten
This article identifies the top-performing industrial stocks for September 2026, highlighting Vicor Corporation (VICR) and Bloom Energy Corporation (BE) as the leaders. The list ranks companies based on their one-month price performance, with several top performers also holding Strong Buy Quant Ratings. The industrial sector showed selective opportunities amidst broader market consolidation and sector rotation.
Form 4 Proto Labs Inc For: 26 September By Investing.com
This article announces the filing of a Form 4 for Proto Labs Inc., pertaining to activity on September 26. It provides the headline for this regulatory filing without further details in the body. The piece also includes various financial market data and related news headlines.
Proto Labs, Inc. (PRLB) stock price, news, quote and history
This page provides a comprehensive overview of Proto Labs, Inc. (PRLB) stock, including its current price, key financial statistics, historical performance, and company profile. As of the market open on the date provided, PRLB was trading at 96.15 USD, experiencing a slight dip, with significant year-to-date and 1-year returns. The company specializes in digital manufacturing of custom parts using services like molding, CNC machining, and 3D printing.
Form 4 Proto Labs Inc For: 26 September By Investing.com
This article announces the filing of a Form 4 for Proto Labs Inc. on September 26. It is a brief financial news update provided by Investing.com, typical for reporting insider transactions or significant company filings. The article itself is very short, primarily serving as a headline for the Form 4 filing.
Proto Labs CFO Daniel Schumacher sells $476,604 in stock
Daniel Schumacher, CFO of Proto Labs Inc (NYSE:PRLB), sold 5,000 shares of company stock for $476,604 on September 24, 2026. This sale was conducted under a Rule 10b5-1 trading plan. The company's stock is trading near its 52-week high and has shown strong returns, while InvestingPro analysis suggests it may be overvalued.
Form 4 Proto Labs Inc For: 26 September By Investing.com
This article announces the filing of Form 4 for Proto Labs Inc. on September 26. It provides no further details about the content of the Form 4 but lists the stock symbol PRLB with a 3.53% increase. The article also includes various market data and other news headlines.
Insider Selling: Proto Labs (NYSE:PRLB) CFO Sells 5,000 Shares of Company Stock
Proto Labs' CFO, Daniel Schumacher, sold 5,000 shares of the company's stock for $476,600, reducing his direct ownership by 12.49%. This transaction occurred under a pre-arranged Rule 10b5-1 trading plan. The company's shares are trading near their 52-week high, with a market capitalization of $2.30 billion, and have received a "Buy" consensus rating from analysts following strong quarterly earnings.
A planned share sale leaves Proto Labs (PRLB) CFO Daniel Schumacher holding 35,019 shares.
Proto Labs' CFO, Daniel Schumacher, sold 5,000 shares of common stock on September 24, 2026, at a weighted average price of $95.3209 per share. This transaction was conducted under a Rule 10b5-1 trading plan adopted on June 5, 2026. Following the sale, Schumacher directly holds 35,019 shares of the company.
After selling 10,753 shares in August, a former Proto Labs (PRLB) officer plans to sell 1,143 more.
Michael R. Kenison, a former officer of Proto Labs, Inc. (PRLB), intends to sell 1,143 common shares valued at approximately $109,493.69, acquired through option exercise. This intended sale follows previous sales by Kenison, including 1,800 shares on September 24, 2026, and 10,753 shares on August 4, 2026, totaling over $1.1 million. The transactions are reported via a Form 144 filing, which outlines the conditions for reselling restricted securities.
After two earlier share sales, a Proto Labs (PRLB) officer plans to sell 5,000 more shares.
Proto Labs officer Daniel Schumacher plans to sell 5,000 common shares with an aggregate market value of $445,650, acquired through restricted stock units. This follows two prior 10b5-1 sales in September 2026 totaling 5,000 shares. The transaction was filed as a Form 144 with the SEC.
Proto Labs (NYSE:PRLB) Trading Up 4.7% - What's Next?
Proto Labs (NYSE:PRLB) saw its shares rise 4.7% to $93.35 during mid-day trading on Thursday, despite lower than average trading volume. The company recently exceeded quarterly earnings and revenue expectations, reporting $0.60 EPS against an expected $0.53 and revenue of $149.34 million, an increase of 10.5% year over year. Analyst sentiment remains largely positive, with a consensus "Buy" rating and an average price target of $89.00, though some recent reports involved downgrades within the "buy" spectrum.
Protolabs Robotics Revenue More Than Doubled in H1 2026 | PRLB Stock News
Protolabs (NYSE: PRLB) announced a significant increase in its robotics-driven revenue, which more than doubled in the first half of 2026 compared to the same period in 2025. The company specializes in rapid digital manufacturing services, providing quick-turn parts for robotics developers to accelerate their product development and go-to-market timelines. Protolabs offers high-speed prototyping and low-volume production through its own factories and the Protolabs Network, supporting an industry projected to grow from $88 billion to $219 billion by 2031.
Proto Labs Inc. (PRZ) Q3 2025 Earnings Report - Results, Call & Slides
Proto Labs Inc. (PRZ) released its Q3 2025 earnings report, showing actual EPS of CHF0.38 against a consensus of CHF0.32, beating expectations by CHF0.06. The company also reported actual revenue of CHF110.20M, surpassing the expected CHF108.97M, with a YoY revenue growth of +7.76%. The next earnings date is estimated for October 30, 2026.
Proto Labs COO Salam Ramahi files initial beneficial ownership statement
Proto Labs' Chief Operations Officer, Salam Ramahi, filed an initial beneficial ownership statement (Form 3) with the SEC, dated August 31, 2026. This news brief was generated by Public Technologies (PUBT) using AI, based on original content filed by Proto Labs Inc. via EDGAR. The information is for informational purposes only and not financial advice.
Protolabs Recognized as One of America's Most Innovative Businesses
Protolabs has been recognized by Business Insider as one of America's Most Innovative Businesses due to its leadership in manufacturing technology. The company holds over 120 patents, invests heavily in R&D, and utilizes physical AI and digital infrastructure to meet changing market demands. CEO Suresh Krishna highlights Protolabs' commitment to leveraging AI-influenced hardware to drive the future of manufacturing and maintain its competitive edge.
Are Industrial Products Stocks Lagging Proto Labs (PRLB) This Year?
Proto Labs (PRLB) has significantly outperformed the Industrial Products sector year-to-date, returning 57.2% compared to the sector's 14.6% gain. The company holds a Zacks Rank #2 (Buy) due to improving analyst sentiment and earnings outlook. However, PRLB is slightly underperforming its specific Rubber - Plastics industry, which has gained an average of 60.4%.
Proto Labs Inc. (0KRR) Q3 2025 Earnings Report - Results, Call & Slides
Proto Labs Inc. (0KRR) reported its Q3 2025 earnings, beating analyst expectations with an actual EPS of $0.47 against a consensus of $0.39 and actual revenue of $135.37M against an expected $133.86M. The company's revenue showed a year-over-year growth of +7.76%. The earnings call was held on October 31, 2025, and the next earnings date is estimated for October 30, 2026.
Proto Labs Inc. (0KRR) Q1 2024 Earnings Report - Results, Call & Slides
Proto Labs Inc. (0KRR) reported its Q1 2024 earnings, beating both EPS and revenue expectations. The company posted an actual EPS of $0.40 against a consensus of $0.32 and actual revenue of $127.89M against an expected $125.53M, marking a 1.61% year-over-year revenue growth. The earnings call took place on May 3, 2024, and the next earnings report is estimated for October 30, 2026.
Protolabs Appoints New Chief Operations Officer
Protolabs has announced the appointment of Sam Ramahi as Chief Operations Officer, effective August 31, 2026. Ramahi brings over 25 years of executive operational leadership experience and will oversee global operations, supply chain, and quality management to enhance the company's service capabilities. His role will focus on driving operational excellence, continuous improvement, and supporting the company's transition from prototype to production with a global perspective.
Protolabs names Sam Ramahi as COO to lead global operations and drive production expansion
Protolabs has appointed Sam Ramahi as its new Chief Operations Officer, effective August 31, 2026. Ramahi will be responsible for leading global operations, supply chain, quality, sourcing, and continuous improvement, supporting the company's strategy to expand from prototype to production. He brings over 25 years of operational experience to the role and will report to CEO Suresh Krishna.
Protolabs' incoming operations chief led 1,300 workers across five plants
Protolabs has appointed Sam Ramahi as its new Chief Operations Officer, effective August 31, 2026. Ramahi brings over 25 years of global operational leadership experience and will be responsible for operations, supply chain, quality, sourcing, and continuous improvement initiatives. His previous role at SIG Group involved leading a 1,300-person organization across five manufacturing facilities and driving significant operational improvements.
Somerville Kurt F Makes New $8.34 Million Investment in Proto Labs, Inc. $PRLB
Somerville Kurt F has made a new $8.34 million investment in Proto Labs, Inc. (NYSE:PRLB), acquiring 91,953 shares in the second quarter of 2026. This investment represents 0.38% of Proto Labs and 2.0% of Somerville Kurt F's total holdings. Other institutional investors have also adjusted their positions in PRLB, which recently reported strong quarterly earnings, beating analyst estimates, despite a slight decline in its stock price.
Puzo Michael J Makes New Investment in Proto Labs, Inc. $PRLB
Puzo Michael J acquired 91,512 shares of Proto Labs, Inc. (NYSE:PRLB) valued at approximately $8.3 million during the second quarter, making it their 20th largest holding and a 0.38% ownership stake in the company. Institutional investors collectively own 84.54% of Proto Labs, which recently traded at $82.11 and exceeded quarterly expectations with adjusted earnings of $0.60 per share and revenue of $149.34 million. Analysts currently maintain a consensus "Buy" rating for PRLB with an $89.00 price target.
Digital Manufacturer Achieves Double-Digit Growth
Proto Labs Inc., a digital manufacturing services provider, reported record second-quarter 2026 revenue of $149.3 million, marking a 10.6% increase year-over-year. This growth was largely driven by robust performance in polymer-based injection molding services, which saw a 13.1% increase, and CNC machining, up 13.6%. The company also achieved significant margin expansion and raised its full-year 2026 revenue growth guidance to between 8% and 10%.
108,964 Shares in Proto Labs, Inc. $PRLB Purchased by Rice Hall James & Associates LLC
Rice Hall James & Associates LLC recently acquired 108,964 shares of Proto Labs, Inc. (NYSE:PRLB) valued at approximately $8.88 million, contributing to institutional ownership of 84.54% of the company. Proto Labs exceeded Q2 earnings expectations with $0.60 EPS and $149.34 million in revenue, an increase of 10.5% year-over-year. The stock has an average "Buy" rating from analysts with an average price target of $89.00, despite a recent insider sale by a director.
State of Wyoming Invests $1.33 Million in Proto Labs, Inc. $PRLB
The State of Wyoming has invested $1.33 million in Proto Labs, Inc. (NYSE:PRLB) by acquiring 16,370 shares during the second quarter. This move is part of broader institutional interest, with hedge funds and institutions collectively owning 84.54% of the company. Proto Labs recently reported strong Q2 earnings, beating analyst estimates with $0.60 EPS and a 10.5% increase in revenue year-over-year, and analysts generally maintain a positive outlook with a "Buy" rating and an average price target of $89.00.
Proto Labs, Inc. $PRLB Shares Sold by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. significantly reduced its holdings in Proto Labs (NYSE: PRLB) by 73.8% in the second quarter, selling 34,538 shares and retaining 12,238 shares valued at approximately $998,000. Despite this, institutional investors collectively own a substantial 84.54% of the company. Proto Labs reported strong quarterly earnings, beating EPS estimates and showing a 10.5% increase in revenue, while analyst sentiment remains largely positive with an average "Buy" rating and an $89 price target.
Disciplined Growth Investors (PRLB) discloses 10% Proto Labs ownership stake
Disciplined Growth Investors, Inc. has reported a 10.0% ownership stake in Proto Labs Inc. common stock, holding 2,380,514 shares as of June 30, 2026. The investment firm based in Minneapolis, Minnesota, maintains sole voting power over 2,244,845 shares and sole dispositive power over all 2,380,514 shares, indicating a passive investment intent. This disclosure was made via a Schedule 13G/A filing, signed by Peter G. Rieke, the Chief Operating & Compliance Officer, on August 14, 2026.
MIT Fellows Will Study How U.S. Factories Scale Aerospace and Medical Technology
Protolabs has provided a grant to the MIT Industrial Performance Center to support research fellows studying how U.S. manufacturing innovators can scale advanced aerospace and medical technologies. This research aims to identify strategies for U.S. manufacturers to turn innovation into large-scale domestic production, thereby strengthening the U.S. economy and national security. The initiative will develop a manufacturing innovation index and advance research on high-growth manufacturing companies in critical industries.
Proto Labs, Inc. $PRLB Position Raised by Quantinno Capital Management LP
Quantinno Capital Management LP significantly increased its stake in Proto Labs, Inc. (NYSE:PRLB) by 98.9% in the first quarter, now owning 27,716 shares valued at $1.58 million. This comes as Proto Labs reported strong quarterly earnings, beating analyst estimates with an EPS of $0.60 and a 10.5% year-over-year revenue increase. The company maintains a "Buy" rating from analysts, with an average price target of $89, reflecting positive sentiment in its financial performance and market position.
Protolabs Supports MIT Industrial Performance Center Research Fellows to Accelerate U.S. Medical and Aerospace Manufacturing Innovation
Protolabs has announced a grant to support research fellows at the MIT Industrial Performance Center. This initiative aims to study leading U.S. manufacturing innovators to identify strategies for scaling advanced technologies, particularly in the medical and aerospace sectors. The research will help U.S. manufacturers turn innovation into domestic production, strengthening the economy and national security, and will include developing a manufacturing innovation index.
Proto Labs Inc stock hits 52-week high at 92.0 USD
Proto Labs Inc. (PRLB) shares have reached a new 52-week high of $92.00, driven by an impressive 90% total return over the past year and nearly 79% year-to-date. This growth follows strong Q2 results, exceeding analyst expectations with record revenue and adjusted earnings, and a recent Needham upgrade to Buy with an $87.00 price target. Despite the strong performance, InvestingPro analysis suggests the stock may be overvalued relative to its Fair Value.
Proto Labs (PRLB) Is Up 11.7% After Raising 2026 Revenue Guidance And Highlighting Rising Customer Spend
Proto Labs (PRLB) saw an 11.7% stock increase after raising its full-year 2026 revenue growth guidance to 8%–10% and reporting strong Q2 results with US$149.34 million in sales and US$9.15 million in net income. The company highlighted a 17% year-over-year increase in revenue per customer, signaling a successful shift towards higher-value production work, especially in aerospace and defense. This positive outlook is further supported by Q3 2026 guidance projecting US$145.0 million to US$153.0 million in revenue and GAAP diluted EPS of US$0.34 to US$0.42.
Apogee Adds Joseph Hayek, Suresh Krishna to Board of Directors
Apogee Enterprises Inc. has expanded its board of directors from six to eight members by electing Joseph Hayek and Suresh Krishna as independent directors. Hayek is the president and CEO of Worthington Enterprises Inc., and Krishna is the president and CEO of Proto Labs Inc. Both bring extensive public company CEO experience, along with deep expertise in operations, manufacturing, supply chain, and technology, which Apogee CEO Don Nolan believes will strengthen the company's strategic execution and value creation for shareholders.
Proto Labs Inc (PRLB) Stock News Today
This page provides the latest news, earnings, analyst ratings, and key developments for Proto Labs Inc (PRLB) stock. It highlights a recent earnings report from Q2 2026, where Protolabs announced record revenue driving margin expansion. The page also displays current stock performance data and financial metrics for PRLB.
Proto Labs (PRLB) insider Kenison plans $947K stock sale in Form 144
Proto Labs (PRLB) shareholder Michael R. Kenison has filed a Form 144, indicating a planned sale of 10,753 shares of common stock valued at approximately $947,786.62 through Morgan Stanley Smith Barney LLC on the NYSE. The filing also details Kenison's prior acquisitions through restricted stock vesting and an employee stock purchase plan, as well as past sales of PRLB shares over the last three months.
Proto Labs stock hits 52-week high at 83.19 USD By Investing.com
Proto Labs Inc (PRLB) has reached a 52-week high of $83.19, with its stock trading at $83.25 and boasting a market capitalization of approximately $2 billion. Despite an InvestingPro assessment suggesting the stock may be overvalued, the company has seen an 85% increase over the past year, driven by strong Q2 results and a Needham upgrade to Buy. The positive trajectory is attributed to operational improvements and continued innovation.
Proto Labs stock hits 52-week high at 83.19 USD By Investing.com
Proto Labs Inc (PRLB) has reached a new 52-week high of $83.19, with the stock currently trading at $83.25. The company recently reported strong second-quarter results, exceeding analyst expectations with record revenue and adjusted earnings, and Needham upgraded its stock rating to Buy. These positive developments reflect significant operational improvements and growth momentum for Proto Labs.
Proto Labs (NYSE:PRLB) Hits New 12-Month High After Analyst Upgrade
Proto Labs (NYSE:PRLB) reached a new 52-week high after Needham & Company LLC upgraded the stock from a "hold" to a "buy" rating with an $87 price target. The company reported strong Q2 earnings, beating analyst estimates, and provided positive Q3 guidance. Despite institutional ownership of over 84%, company insiders have recently sold shares, reducing their total ownership to 1.30%.
19,015 Shares in Proto Labs, Inc. $PRLB Acquired by Edgestream Partners L.P.
Edgestream Partners L.P. acquired a new stake of 19,015 shares in Proto Labs, Inc. (NYSE:PRLB) during the first quarter, valued at approximately $1.08 million. Institutional investors collectively own 84.54% of the company's stock, despite some insider selling totaling $1.80 million during the last quarter. Proto Labs reported strong quarterly earnings, beating analyst estimates for both EPS and revenue, and maintains a "Moderate Buy" consensus rating with an average price target of $89 from analysts.
Proto Labs stock hits 52-week high at 83.19 USD By Investing.com
Proto Labs Inc (PRLB) has hit a new 52-week high of $83.19, reflecting an 85% stock price increase over the past year and significant year-to-date and six-month gains. This surge follows strong Q2 results, exceeding Wall Street expectations with record revenue and adjusted earnings, and an upgrade from Hold to Buy by Needham. Despite being potentially overvalued according to InvestingPro data, investor confidence is boosted by the company's operational improvements and positive outlook.
Proto Labs Inc (PRLB) (Q2 2026) Earnings Call Highlights: Record Revenue and Raised Guidance ...
Proto Labs Inc (PRLB) reported record Q2 2026 revenue of $149.3 million, a 10.2% year-over-year increase in constant currencies, and raised its full-year 2026 revenue growth outlook to 8-10%. The company saw strong growth in injection molding and CNC machining, particularly in the aerospace and defense sectors, contributing to an adjusted EPS of $0.60. Despite a decline in 3D printing revenue and flat network revenue, Proto Labs highlighted strategic investments in AI and customer experience improvements as key drivers for future growth and profitability, especially in the European market which remains a work in progress.
Proto Labs, Inc. Revenue Breakdown – NYSE:PRLB
Proto Labs, Inc. (NYSE: PRLB) reported a total revenue of $533.13 million USD last year. The Computer Numerical Control Machining segment was the top performer, contributing $243.33 million USD. The majority of the company's revenue, $432.33 million USD, was generated from the United States market.
Proto Labs Inc Q2 2026: Revenue $149.34M, EPS $0.37— 10-Q Summary
Proto Labs Inc reported strong Q2 2026 results, with revenue reaching $149.34 million and diluted EPS of $0.37. This significant growth, compared to Q2 2025, was primarily driven by increased CNC and injection molding sales and improved gross margins. The company also focused on larger strategic customers, leading to a 17% increase in revenue per contact, despite serving fewer overall customers.
Proto Labs sees injection molding surge as drone, data center demands reshape business
Proto Labs is experiencing a surge in demand for its injection molding services, driven by growth in the drone and data center industries. This shift highlights how emerging technologies are reshaping the business landscape for manufacturing companies like Proto Labs, focusing on critical components for these sectors. The company is adapting to these evolving market needs by leveraging its rapid manufacturing capabilities.
Proto Labs Q2 Earnings Call Highlights
Proto Labs (NYSE:PRLB) reported record second-quarter revenue, up 10.2% year-over-year in constant currency, driven by strong demand in CNC machining and injection molding. The company's non-GAAP EPS increased by 45% to $0.60. Management raised its full-year 2026 revenue growth outlook to 8% to 10% and provided Q3 revenue guidance of $145 million to $153 million, while also highlighting progress in its European commercial transformation and ongoing evaluation of acquisition opportunities.
